Emmes Publications | Emmes

Search

Show only items where

Author

Type

Term

Year

Keyword

Found 11 results

Author Title Type [ Year

]

Filters: Author is Hammel, K [Clear All Filters]

2015

Petrou, PA, D Cunningham, K Shimel, M Harrington, K Hammel, CA Cukras, FL Ferris, EY Chew, and WT Wong. 2015. “Intravitreal Sirolimus For The Treatment Of Geographic Atrophy: Results Of A Phase I/ii Clinical Trial”. Invest Ophthalmol Vis Sci 56. Invest Ophthalmol Vis Sci: 330-338. http://www.ncbi.nlm.nih.gov/pubmed/25525171.

2013

Wong, WT, S Dresner, F Forooghian, T Glaser, L Doss, M Zhou, D Cunningham, et al.. 2013. “Treatment Of Geographic Atrophy With Subconjunctival Sirolimus: Results Of A Phase I/ii Clinical Trial”. Invest Ophthalmol Vis Sci 54. Invest Ophthalmol Vis Sci: 2941-2950. http://www.ncbi.nlm.nih.gov/pubmed/23548622.

2010

Chew, E, J Kim, H Coleman, L Aiello, G Fish, M Ip, J Haller, et al.. 2010. “Preliminary Assessment Of Celecoxib And Microdiode Pulse Laser Treatment Of Diabetic Macular Edema”. Retina 30. Retina: 459-467. http://www.ncbi.nlm.nih.gov/pubmed/20038863.

Wong, W, W Kam, D Cunningham, M Harrington, K Hammel, C Meyerle, C Cukras, E Chew, S Sadda, and F Ferris. 2010. “Treatment Of Geographic Atrophy By The Topical Administration Of Ot-551: Results Of A Phase Ii Clinical Trial”. Invest Ophthlmol Vis Sci 51. Invest Ophthlmol Vis Sci: 613-619. http://www.ncbi.nlm.nih.gov/pubmed/20574018.

2009

Sen, H, G Levy-Clarke, L Faia, Z Li, S Yeh, K Barron, J Ryan, K Hammel, and R Nussenblatt. 2009. “High-Dose Daclizumab For The Treatment Of Juvenile Idiopathic Arthritis-Associated Active Anterior Uveitis”. Am J Ophthalmol 148. Am J Ophthalmol: 696-703.e1. http://www.ncbi.nlm.nih.gov/pubmed?term=19664754.

Sen, HN, A Sangave, K Hammel, G Levy-Clarke, and RB Nussenblatt. 2009. “Infliximab For The Treatment Of Active Scleritis”. Can J Ophthalmol 44. Can J Ophthalmol: e9-e12. http://www.ncbi.nlm.nih.gov/pubmed/19506593.

2008

DeStefano, J, R Ferguson, R Hall, K Hammel, J Lum, E Murphy, and K Nelson. 2008. “Electronic Data Acquisition”. In Society For Clinical Trials. Society For Clinical Trials. St. Louis MO.

Sen, HN, R Buggage, K Hammel, G Levy-Clarke, and R Nussenblatt. 2008. “Infliximab For The Treatment Of Scleritis And Recalcitrant Uveitis”.

Liang, KJ, WT Wong, K Hammel, H Coleman, and E Chew. 2008. “Intravitreal Ranibizumab For Treatment Of Retinal Capillary Hemangioblastoma (Rch) Related To Von-Hippel Lindau (Vhl) Disease”. In Association For Research In Vision And Ophthalmology (Arvo). Association For Research In Vision And Ophthalmology (Arvo). Ft. Lauderdale, FL.

Wong, WT, K Liang, K Hammel, HR Coleman, and EY Chew. 2008. “Intravitreal Ranibizumab Therapy For Retinal Capillary Hemangioblastoma Related To Von Hippel-Lindau Disease”. Ophthalmology 115. Ophthalmology: 1957-1964. http://www.ncbi.nlm.nih.gov/pubmed/18789534.

2006

Csaky, K, B Blodi, M Osman, S Cousin, D Callanan, and K Hammel. 2006. “The Utility Of Dynamic Indocyanine Green Angiography (D-Icg) In Patients With Neovascular Age-Related Macular Degeneration (Amd) As Determined By Two Prospective Clinical Trials”.